**New Treatment Option Available for Rare Neurological Disorder** We are pleased to announce that the Food and Drug Administration (FDA) has approved leucovorin as a treatment for cerebral folate deficiency, a rare neurological disorder.
**New Treatment Option Available for Rare Neurological Disorder**We are pleased to announce that the Food and Drug Administration (FDA) has approved leucovorin as a treatment for cerebral folate deficiency, a rare neurological disorder.
Cerebral folate deficiency is a condition characterized by low levels of vitamin B9 in the brain. It can cause developmental delays, seizures, and movement abnormalities in young children. While it's estimated that only 1 in 1 million people worldwide have this condition, research suggests that 38-70% of autistic children may have cerebral folate deficiency.
Leucovorin is a prescription medication used primarily to help alleviate the side effects of chemotherapy. However, its approval for cerebral folate deficiency marks an important milestone in providing relief for individuals with this rare condition.
About Leucovorin
Leucovorin works by helping to restore folic acid to healthy cells that have been depleted by the effects of chemotherapy. It is considered effective as a "rescue agent" for people undergoing certain types of chemotherapy.
Treatment Options and Research
While leucovorin has been approved for cerebral folate deficiency, more research is needed to determine its effectiveness as a treatment for autism. Experts agree that further studies are necessary before leucovorin can be approved for this purpose.
Our clinic remains committed to providing the latest and most effective treatments for our patients. We will continue to monitor developments in the field and provide updates on any new research or findings related to leucovorin and cerebral folate deficiency.
Learn more about hair transplant at Rubenhair clinic.
Get a Free Consultation
Consult with our specialists about FUE procedure, PRP therapy or hair transplant.
